Literature DB >> 25253827

Is axillary sonographic staging less accurate in invasive lobular breast cancer than in ductal breast cancer?

Prashant Sankaye1, Sharmila Chhatani2, Gareth Porter2, Jim Steel2, Sarah Doyle2.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether axillary sonography is less accurate in invasive lobular breast cancer than in ductal breast cancer.
METHODS: Patients with invasive breast cancer were retrospectively identified from histologic records from 2010 to 2012. Staging axillary sonograms from 96 patients with primary breast cancer in each of 2 subgroups, invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC), were reviewed. Preoperative sonographically guided 14-gauge core biopsy was performed on morphologically abnormal lymph nodes.
RESULTS: Thirty-one of 96 patients (32%) in each subgroup were node positive on final postoperative histopathologic analysis. Axillary staging sensitivity was 17 of 31 patients (54%) in the IDC subgroup and 15 of 31(48%) in the ILC subgroup. Further analysis of the data showed no statistically significant differences between these subgroups.
CONCLUSIONS: We found that there was no statistically significant difference in the accuracy of axillary sonographic staging between ILC and IDC.
© 2014 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  axillary sonography; breast cancer; breast ultrasound; invasive lobular breast cancer

Mesh:

Year:  2014        PMID: 25253827     DOI: 10.7863/ultra.33.10.1805

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  2 in total

1.  Prediction of axillary nodal burden in patients with invasive lobular carcinoma using MRI.

Authors:  Su Min Ha; Jung Min Chang; Soo-Yeon Kim; Su Hyun Lee; Eun Sil Kim; Yeon Soo Kim; Nariya Cho; Woo Kyung Moon
Journal:  Breast Cancer Res Treat       Date:  2021-01-03       Impact factor: 4.872

2.  Pre-operative and intra-operative detection of axillary lymph node metastases in 108 patients with invasive lobular breast cancer undergoing mastectomy.

Authors:  Jerica Novak; Nikola Besic; Radan Dzodic; Barbara Gazic; Andrej Vogrin
Journal:  BMC Cancer       Date:  2018-02-05       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.